78 related articles for article (PubMed ID: 20156030)
1. Immunomodulatory effects of antifungal agents on the response of human monocytic cells to Aspergillus fumigatus conidia.
Choi JH; Kwon EY; Park CM; Choi SM; Lee DG; Yoo JH; Shin WS; Stevens DA
Med Mycol; 2010 Aug; 48(5):704-9. PubMed ID: 20156030
[TBL] [Abstract][Full Text] [Related]
2. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G
J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors.
Simitsopoulou M; Roilides E; Paliogianni F; Likartsis C; Ioannidis J; Kanellou K; Walsh TJ
Antimicrob Agents Chemother; 2008 Sep; 52(9):3301-6. PubMed ID: 18625774
[TBL] [Abstract][Full Text] [Related]
4. Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus.
Simitsopoulou M; Roilides E; Georgiadou E; Paliogianni F; Walsh TJ
Med Mycol; 2011 Feb; 49(2):176-85. PubMed ID: 20807031
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor kappaB and nuclear factor kappaB in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia.
Choi JH; Brummer E; Kang YJ; Jones PP; Stevens DA
J Infect Dis; 2006 Apr; 193(7):1023-8. PubMed ID: 16518765
[TBL] [Abstract][Full Text] [Related]
6. Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
Chryssanthou E; Loebig A; Sjölin J
J Antimicrob Chemother; 2008 Jun; 61(6):1309-11. PubMed ID: 18367461
[TBL] [Abstract][Full Text] [Related]
7. Expression turnover profiling to monitor the antifungal activities of amphotericin B, voriconazole, and micafungin against Aspergillus fumigatus.
Zhao Y; Paderu P; Park S; Dukhan A; Senter M; Perlin DS
Antimicrob Agents Chemother; 2012 May; 56(5):2770-2. PubMed ID: 22314535
[TBL] [Abstract][Full Text] [Related]
8. Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus.
Simitsopoulou M; Roilides E; Likartsis C; Ioannidis J; Orfanou A; Paliogianni F; Walsh TJ
Antimicrob Agents Chemother; 2007 Mar; 51(3):1048-54. PubMed ID: 17178797
[TBL] [Abstract][Full Text] [Related]
9. Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Vora S; Chauhan S; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1998 Sep; 42(9):2299-303. PubMed ID: 9736553
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effect of mesenchymal stem cells on the immune response of macrophages stimulated by Aspergillus fumigatus conidia.
Cho SY; Kwon EY; Choi SM; Lee DG; Park C; Park SH; Yoo JH; Choi JH
Med Mycol; 2016 May; 54(4):377-83. PubMed ID: 26768375
[TBL] [Abstract][Full Text] [Related]
11. Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration.
Chryssanthou E; Sjölin J
J Antimicrob Chemother; 2004 Nov; 54(5):940-3. PubMed ID: 15471994
[TBL] [Abstract][Full Text] [Related]
12. Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs.
Salvenmoser S; Seidler MJ; Dalpke A; Müller FM
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):74-7. PubMed ID: 20626764
[TBL] [Abstract][Full Text] [Related]
13. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
Krishnan-Natesan S; Wu W; Chandrasekar PH
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):135-7. PubMed ID: 22608136
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
Krishnan S; Manavathu EK; Chandrasekar PH
J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
[TBL] [Abstract][Full Text] [Related]
16. Novel effect of voriconazole on conidiation of Aspergillus species.
Varanasi NL; Baskaran I; Alangaden GJ; Chandrasekar PH; Manavathu EK
Int J Antimicrob Agents; 2004 Jan; 23(1):72-9. PubMed ID: 14732317
[TBL] [Abstract][Full Text] [Related]
17. Candin family antifungal agent micafungin (FK463) modulates the inflammatory cytokine production stimulated by lipopolysaccharide in THP-1 cells.
Kinoshita K; Iwasaki H; Uzui H; Ueda T
Transl Res; 2006 Oct; 148(4):207-13. PubMed ID: 17002923
[TBL] [Abstract][Full Text] [Related]
18. Toll like receptor 5 (TLR5) may be involved in the immunological response to Aspergillus fumigatus in vitro.
Rødland EK; Ager-Wick E; Halvorsen B; Müller F; Frøland SS
Med Mycol; 2011 May; 49(4):375-9. PubMed ID: 21067314
[TBL] [Abstract][Full Text] [Related]
19. Triggering of toll-like receptors 2 and 4 by Aspergillus fumigatus conidia in immortalized human corneal epithelial cells to induce inflammatory cytokines.
Zhao J; Wu XY
Chin Med J (Engl); 2008 Mar; 121(5):450-4. PubMed ID: 18364120
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of moxifloxacin on IL-8, IL-1beta and TNF-alpha secretion and NFkappaB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus.
Shalit I; Halperin D; Haite D; Levitov A; Romano J; Osherov N; Fabian I
J Antimicrob Chemother; 2006 Feb; 57(2):230-5. PubMed ID: 16352735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
